As ADAM10 acts primarily at the cell membrane to cleave close-proximity targets (Hitschler and Lang, 2022), the plasma and CSF activity levels may reflect a decreased amount of functionally active ADAM10, therefore, explaining reduced ADAM10 activity in AD. The gene discussed is ADAM10; the disease is Alzheimer disease.